Hepatitis B Vaccine (Recombinant, VBI Vaccines)

N/A

Report date: 2026/03/12 20:00:16

Base Information

Drug NameHepatitis B Vaccine (Recombinant, VBI Vaccines)
Drug Alias NameBio-Hep-B3-Antigen Hepatitis B vaccine3-Antigen Prophylactic Hepatitis B Vaccine(VIB Vaccines)3-Antigen Vaccine3A-HBV +[11] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIsrael
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesVietnam +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVbi Vaccines Inc
China Registration ClassN/A

Develop Information

Active CompaniesVbi Vaccines IncValneva SEBrii Biosciences Ltd
Inactive CompaniesVBI Vaccines BV
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A